questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Peptide hydrolases
Metalloproteases
Metalloproteases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Métalloprotéases
Biopsie
Tests sanguins
Marqueurs biologiques
Métalloprotéases
Sérum
Imagerie médicale
Métalloprotéases
Tissus
Tests génétiques
Métalloprotéases
Mutations
Activité enzymatique
Métalloprotéases
Échantillons biologiques
Symptômes
5
Inflammation
Métalloprotéases
Douleurs articulaires
Métalloprotéases
Symptômes
Tissus
Cicatrisation
Métalloprotéases
Matrice extracellulaire
Asymptomatique
Métalloprotéases
Dysfonction
Âge
Métalloprotéases
Symptômes dégénératifs
Prévention
5
Prévention
Métalloprotéases
Mode de vie sain
Suppléments nutritionnels
Métalloprotéases
Antioxydants
Alimentation
Métalloprotéases
Inflammation
Stress
Métalloprotéases
Gestion du stress
Examens médicaux
Métalloprotéases
Déséquilibres enzymatiques
Traitements
5
Inhibiteurs
Métalloprotéases
Traitements
Thérapie génique
Métalloprotéases
Mutations
Anti-inflammatoires
Métalloprotéases
Inflammation
Médecine personnalisée
Métalloprotéases
Traitements
Effets secondaires
Inhibiteurs
Métalloprotéases
Complications
5
Complications
Métalloprotéases
Arthrite
Réversibilité
Métalloprotéases
Traitement
Qualité de vie
Métalloprotéases
Douleurs chroniques
Prévisibilité
Métalloprotéases
Surveillance
Complications
Métalloprotéases
Cicatrisation
Facteurs de risque
5
Facteurs de risque
Métalloprotéases
Mode de vie
Antécédents familiaux
Métalloprotéases
Risque
Tabagisme
Métalloprotéases
Maladies
Stress chronique
Métalloprotéases
Risque
Toxines
Métalloprotéases
Environnement
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Metalloproteases : Questions médicales les plus fréquentes",
"headline": "Metalloproteases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Metalloproteases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Metalloproteases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Peptide hydrolases",
"url": "https://questionsmedicales.fr/mesh/D010447",
"about": {
"@type": "MedicalCondition",
"name": "Peptide hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D010447",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Metalloendopeptidases",
"alternateName": "Metalloendopeptidases",
"url": "https://questionsmedicales.fr/mesh/D008666",
"about": {
"@type": "MedicalCondition",
"name": "Metalloendopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D008666",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Collagenases",
"alternateName": "Collagenases",
"url": "https://questionsmedicales.fr/mesh/D017364",
"about": {
"@type": "MedicalCondition",
"name": "Collagenases",
"code": {
"@type": "MedicalCode",
"code": "D017364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Microbial collagenase",
"alternateName": "Microbial Collagenase",
"url": "https://questionsmedicales.fr/mesh/D003012",
"about": {
"@type": "MedicalCondition",
"name": "Microbial collagenase",
"code": {
"@type": "MedicalCode",
"code": "D003012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Microbial collagenase",
"alternateName": "Microbial Collagenase",
"url": "https://questionsmedicales.fr/mesh/D003012",
"about": {
"@type": "MedicalCondition",
"name": "Microbial collagenase",
"code": {
"@type": "MedicalCode",
"code": "D003012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Enzymes de conversion de l'endothéline",
"alternateName": "Endothelin-Converting Enzymes",
"url": "https://questionsmedicales.fr/mesh/D000072396",
"about": {
"@type": "MedicalCondition",
"name": "Enzymes de conversion de l'endothéline",
"code": {
"@type": "MedicalCode",
"code": "D000072396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.229"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gelatinases",
"alternateName": "Gelatinases",
"url": "https://questionsmedicales.fr/mesh/D018093",
"about": {
"@type": "MedicalCondition",
"name": "Gelatinases",
"code": {
"@type": "MedicalCode",
"code": "D018093",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.252"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Insulinase",
"alternateName": "Insulysin",
"url": "https://questionsmedicales.fr/mesh/D007339",
"about": {
"@type": "MedicalCondition",
"name": "Insulinase",
"code": {
"@type": "MedicalCode",
"code": "D007339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lysostaphin",
"alternateName": "Lysostaphin",
"url": "https://questionsmedicales.fr/mesh/D008248",
"about": {
"@type": "MedicalCondition",
"name": "Lysostaphin",
"code": {
"@type": "MedicalCode",
"code": "D008248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.452"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinases",
"alternateName": "Matrix Metalloproteinases",
"url": "https://questionsmedicales.fr/mesh/D020782",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinases",
"code": {
"@type": "MedicalCode",
"code": "D020782",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 14",
"alternateName": "Matrix Metalloproteinase 14",
"url": "https://questionsmedicales.fr/mesh/D053511",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 14",
"code": {
"@type": "MedicalCode",
"code": "D053511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 15",
"alternateName": "Matrix Metalloproteinase 15",
"url": "https://questionsmedicales.fr/mesh/D053517",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 15",
"code": {
"@type": "MedicalCode",
"code": "D053517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 16",
"alternateName": "Matrix Metalloproteinase 16",
"url": "https://questionsmedicales.fr/mesh/D053513",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 16",
"code": {
"@type": "MedicalCode",
"code": "D053513",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 14",
"alternateName": "Matrix Metalloproteinase 14",
"url": "https://questionsmedicales.fr/mesh/D053511",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 14",
"code": {
"@type": "MedicalCode",
"code": "D053511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 15",
"alternateName": "Matrix Metalloproteinase 15",
"url": "https://questionsmedicales.fr/mesh/D053517",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 15",
"code": {
"@type": "MedicalCode",
"code": "D053517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 16",
"alternateName": "Matrix Metalloproteinase 16",
"url": "https://questionsmedicales.fr/mesh/D053513",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 16",
"code": {
"@type": "MedicalCode",
"code": "D053513",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Procollagen peptidase",
"alternateName": "Procollagen N-Endopeptidase",
"url": "https://questionsmedicales.fr/mesh/D011348",
"about": {
"@type": "MedicalCondition",
"name": "Procollagen peptidase",
"code": {
"@type": "MedicalCode",
"code": "D011348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.664"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bacillus thermoproteolyticus neutral proteinase",
"alternateName": "Thermolysin",
"url": "https://questionsmedicales.fr/mesh/D013820",
"about": {
"@type": "MedicalCondition",
"name": "Bacillus thermoproteolyticus neutral proteinase",
"code": {
"@type": "MedicalCode",
"code": "D013820",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.827"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Metalloexopeptidases",
"alternateName": "Metalloexopeptidases",
"url": "https://questionsmedicales.fr/mesh/D045727",
"about": {
"@type": "MedicalCondition",
"name": "Metalloexopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D045727",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Carboxypeptidases A",
"alternateName": "Carboxypeptidases A",
"url": "https://questionsmedicales.fr/mesh/D043422",
"about": {
"@type": "MedicalCondition",
"name": "Carboxypeptidases A",
"code": {
"@type": "MedicalCode",
"code": "D043422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystinyl aminopeptidase",
"alternateName": "Cystinyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D010122",
"about": {
"@type": "MedicalCondition",
"name": "Cystinyl aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D010122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutamate carboxypeptidase II",
"alternateName": "Glutamate Carboxypeptidase II",
"url": "https://questionsmedicales.fr/mesh/D043425",
"about": {
"@type": "MedicalCondition",
"name": "Glutamate carboxypeptidase II",
"code": {
"@type": "MedicalCode",
"code": "D043425",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutamyl aminopeptidase",
"alternateName": "Glutamyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D043384",
"about": {
"@type": "MedicalCondition",
"name": "Glutamyl aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D043384",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leucyl Aminopeptidase",
"alternateName": "Leucyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D007931",
"about": {
"@type": "MedicalCondition",
"name": "Leucyl Aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D007931",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lysine carboxypeptidase",
"alternateName": "Lysine Carboxypeptidase",
"url": "https://questionsmedicales.fr/mesh/D001121",
"about": {
"@type": "MedicalCondition",
"name": "Lysine carboxypeptidase",
"code": {
"@type": "MedicalCode",
"code": "D001121",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Metalloproteases",
"alternateName": "Metalloproteases",
"code": {
"@type": "MedicalCode",
"code": "D045726",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tania Fontanil",
"url": "https://questionsmedicales.fr/author/Tania%20Fontanil",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Yamina Mohamedi",
"url": "https://questionsmedicales.fr/author/Yamina%20Mohamedi",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Teresa Cobo",
"url": "https://questionsmedicales.fr/author/Teresa%20Cobo",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Cirugía y Especialidades Médico-Quirúrgicas, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Santiago Cal",
"url": "https://questionsmedicales.fr/author/Santiago%20Cal",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Álvaro J Obaya",
"url": "https://questionsmedicales.fr/author/%C3%81lvaro%20J%20Obaya",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biología Funcional, Área de Fisiología, Universidad de Oviedo, 33006 Oviedo, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Influence of Probiotics Consumption on Management of Prediabetic State: A Systematic Review of Clinical Trials.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36160290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/5963679"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trends and disparities in diabetes and prediabetes among adults in the United States, 1999-2018.",
"datePublished": "2022-12-29",
"url": "https://questionsmedicales.fr/article/36586345",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.puhe.2022.10.021"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuropathy in prediabetes.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37470302",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/dmrr.3693"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prediabetes and skeletal health.",
"datePublished": "2023-05-29",
"url": "https://questionsmedicales.fr/article/37248797",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MED.0000000000000812"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perspectives on Prediabetes and Aging.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36948785",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ecl.2022.10.011"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Peptide hydrolases",
"item": "https://questionsmedicales.fr/mesh/D010447"
},
{
"@type": "ListItem",
"position": 6,
"name": "Metalloproteases",
"item": "https://questionsmedicales.fr/mesh/D045726"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Metalloproteases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Metalloproteases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Metalloproteases",
"description": "Comment diagnostiquer une dysfonction des métalloprotéases ?\nQuels marqueurs sont utilisés pour le diagnostic ?\nLes imageries sont-elles utiles pour le diagnostic ?\nQuels tests génétiques sont disponibles ?\nComment évaluer l'activité enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prediabetic+State#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Metalloproteases",
"description": "Quels symptômes indiquent une surproduction de métalloprotéases ?\nLes symptômes varient-ils selon le type de métalloprotéases ?\nQuels signes cliniques sont associés à une déficience ?\nLes symptômes sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prediabetic+State#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Metalloproteases",
"description": "Comment prévenir les maladies liées aux métalloprotéases ?\nLes suppléments nutritionnels sont-ils utiles ?\nL'évitement de certains aliments est-il recommandé ?\nLe contrôle du stress est-il important ?\nLes examens réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prediabetic+State#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Metalloproteases",
"description": "Quels traitements ciblent les métalloprotéases ?\nLes thérapies géniques sont-elles une option ?\nComment les anti-inflammatoires aident-ils ?\nLes traitements sont-ils personnalisés ?\nQuels sont les effets secondaires des inhibiteurs ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prediabetic+State#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Metalloproteases",
"description": "Quelles complications peuvent survenir avec une suractivité ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles prévisibles ?\nQuelles sont les complications liées à une déficience ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prediabetic+State#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Metalloproteases",
"description": "Quels facteurs augmentent le risque de dysfonction ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLe stress chronique influence-t-il le risque ?\nL'exposition à des toxines est-elle un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prediabetic+State#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des métalloprotéases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies tissulaires peuvent évaluer l'activité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de métalloprotéases dans le sérum ou les tissus peuvent servir de marqueurs diagnostiques."
}
},
{
"@type": "Question",
"name": "Les imageries sont-elles utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'imagerie peut aider à visualiser les tissus affectés par des déséquilibres enzymatiques."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont disponibles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent identifier des mutations affectant la production de métalloprotéases."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité enzymatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques spécifiques mesurent l'activité des métalloprotéases dans les échantillons."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surproduction de métalloprotéases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une inflammation, des douleurs articulaires et des lésions tissulaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de métalloprotéases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, différents types de métalloprotéases peuvent causer des symptômes variés selon les tissus affectés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une déficience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une cicatrisation lente et des anomalies dans la matrice extracellulaire peuvent être observées."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines dysfonctions peuvent être asymptomatiques jusqu'à des stades avancés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité des métalloprotéases peut augmenter avec l'âge, aggravant les symptômes dégénératifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux métalloprotéases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les antioxydants, peuvent soutenir la fonction des métalloprotéases."
}
},
{
"@type": "Question",
"name": "L'évitement de certains aliments est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, réduire les aliments pro-inflammatoires peut aider à réguler l'activité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut influencer l'activité des métalloprotéases, donc sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers peuvent aider à détecter précocement des déséquilibres enzymatiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les métalloprotéases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des métalloprotéases sont utilisés pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique peut corriger des mutations affectant la production de métalloprotéases."
}
},
{
"@type": "Question",
"name": "Comment les anti-inflammatoires aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'inflammation causée par une suractivité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction du type de métalloprotéases impliqué."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des inhibiteurs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs peuvent causer des effets secondaires comme des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une suractivité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies dégénératives, comme l'arthrite, peuvent résulter d'une suractivité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs chroniques et une mobilité réduite, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles en surveillant les niveaux d'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications liées à une déficience ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une cicatrisation lente et des infections peuvent survenir en raison d'une déficience en métalloprotéases."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysfonction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le mode de vie sédentaire et une alimentation déséquilibrée augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies liées aux métalloprotéases peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut exacerber l'activité des métalloprotéases et augmenter les maladies associées."
}
},
{
"@type": "Question",
"name": "Le stress chronique influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber l'équilibre des métalloprotéases, augmentant le risque de maladies."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut affecter l'activité des métalloprotéases."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain.
Departamento de Investigación, Instituto Ordóñez, 33012 Oviedo, Spain.
Publications dans "Metalloproteases" :
4 publications dans cette catégorie
Affiliations :
Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain.
Publications dans "Metalloproteases" :
4 publications dans cette catégorie
Affiliations :
Departamento de Cirugía y Especialidades Médico-Quirúrgicas, Universidad de Oviedo, 33006 Oviedo, Spain.
Instituto Asturiano de Odontología, 33006 Oviedo, Spain.
Publications dans "Metalloproteases" :
4 publications dans cette catégorie
Affiliations :
Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain.
Instituto Universitario de Oncología, IUOPA, Universidad de Oviedo, 33006 Oviedo, Spain.
Publications dans "Metalloproteases" :
3 publications dans cette catégorie
Affiliations :
Departamento de Biología Funcional, Área de Fisiología, Universidad de Oviedo, 33006 Oviedo, Spain.
Instituto Universitario de Oncología, IUOPA, Universidad de Oviedo, 33006 Oviedo, Spain.
Publications dans "Metalloproteases" :
3 publications dans cette catégorie
Affiliations :
Unit for Degradomics of the Protease Web, Biochemical Institute, University of Kiel, Kiel, Germany. cbeckerpauly@biochem.uni-kiel.de.
Publications dans "Metalloproteases" :
3 publications dans cette catégorie
Affiliations :
Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.
Publications dans "Metalloproteases" :
3 publications dans cette catégorie
Affiliations :
Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.
Publications dans "Metalloproteases" :
3 publications dans cette catégorie
Affiliations :
Department of Physics, Colorado School of Mines, 1500 Illinois Street, Golden, CO, 80401, USA.
Publications dans "Metalloproteases" :
3 publications dans cette catégorie
Affiliations :
Department of Physics, Colorado School of Mines, 1500 Illinois Street, Golden, CO, 80401, USA. ssarkar@mines.edu.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Otto-von-Guericke-University Magdeburg, Medical Faculty, Magdeburg, Germany. Electronic address: christoph.garbers@med.ovgu.de.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
Department of Biology, East Carolina University, Greenville, NC 27858, USA. Electronic address: zhuy@ecu.edu.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
Unit for Degradomics of the Protease Web, Biochemical Institute, University of Kiel, Kiel, Germany.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Institute for Advanced Study, Technical University Munich, Munich, Germany.
Munich Center for Systems Neurology (SyNergy), Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
College of Biology and Pharmaceutical Engineering, Anhui Engineering Laboratory for Conservation and Sustainable Utilization of Traditional Chinese Medicine Resources, West Anhui University, Lu'an City 237012, China.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Metalloproteases" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Publications dans "Metalloproteases" :
Prediabetes consists of the intermediary stage between normal glucose regulation and overt diabetes mellitus and develops when blood glucose levels are higher than normal but not high enough to confir...
The aims of the study were to describe the up-to-date trend of total, diagnosed, and undiagnosed diabetes and prediabetes, assess their associated disparities among population subgroups, and examine t...
This was a cross-sectional study from a nationally representative sample of US adults (aged ≥20 years) who participated in the National Health and Nutrition Examination Survey....
Diagnosed diabetes was defined as a self-reported previous diagnosis of diabetes by a physician or any other health professionals (other than during pregnancy). Undiagnosed diabetes was defined as ele...
A total of 21,600 (mean, 47.2 years [SD, 14.7]) individuals were analyzed. From 1999 to 2018, the age-standardized prevalence increased significantly from 9.17% to 14.7% (difference, 5.52%; 95% confid...
The prevalence of diabetes and prediabetes increased significantly from 1999 to 2018 among US adults. There are substantial and persistent disparities among racial and ethnic minorities, populations e...
Diabetic neuropathies are the most frequent complications of diabetes, contributing to high morbidity, excess mortality, reduced quality of life, and increased healthcare costs. Prediabetes is charact...
Type 2 diabetes mellitus (T2D) confers a greater risk of skeletal fragility and fracture. Whether prediabetes is detrimental to bone health is uncertain....
We summarize the current data on the associations of prediabetes with bone turnover, bone mineral density, bone quality, bone material properties and fracture risk....
In cross-sectional studies, prediabetes was associated with lower bone turnover and worse trabecular bone quality. A longitudinal analysis showed that larger increase in insulin resistance (in the abs...
Diabetes prevention programs (DPPs) have been shown to effectively delay, and sometimes prevent, the progression from prediabetes to diabetes; however, labeling someone with prediabetes comes with pot...
To estimate the prevalence of prediabetes and to assess the association of prediabetic stages with sociodemographic, lifestyle and clinical factors DESIGN: Cross-sectional study at the screening and i...
A total of 6222 residents of two study sites, aged 18-64 years and without a history of diabetes, were eligible for prediabetes screening. Exclusion criteria were pregnancy, history of diabetes and cr...
Prevalence of prediabetes based on glycated haemoglobin (HbA1c) criteria (5.7%-6.4%) was the primary outcome of the study. Odds Ratio and 95% CI were estimated to assess the associations between the o...
Out of 6222 screened participants, 308 (5%, 95% CI: 4.4% to 5.5%) individuals were detected with prediabetes based on HbA1c. The mean age of 291 responded participants was 50.3±7.6 years and 67% were ...
The estimated prevalence of prediabetes was 5% among screened participants, and female gender was associated with the prediabetic stage. As a large proportion of the population with prediabetes were n...
NCT04074148, 2019/783....
Prediabetes is characterized by abnormal glycemic levels below the type 2 diabetes threshold, and effective control of blood glucose may prevent the progression to type 2 diabetes. While the associati...
India is witnessing an epidemic of type 2 diabetes. Overweight/obesity, overnutrition, physical inactivity, and family history are well-known risk factors for diabetes. We investigated the role of und...
DERVAN cohort study was set up in the KONKAN region of the western Indian state of Maharashtra. It enrolled 1,520 adolescent girls (16-18 years old at the time of enrollment). We measured glycemic par...
The median age of the subjects was 16.6 years. The median weight, height, and BMI were 40.7 kg, 151.7 cm, and 17.5 kg/m...
We have reported a high prevalence of prediabetes among rural adolescent girls with a very low prevalence of obesity. Prediabetes in obesity is driven by hyperinsulinemia and overworking of the pancre...
Type II diabetes mellitus is a chronic medical condition affecting societies worldwide. The duration of hyperglycemia is a strong predictor of adverse outcomes and imposes immense clinical and public ...
Patients at a large urban academic medical center were not consistently identified as having a high risk of hyperglycemia....
The project used a pretest-posttest design. Retrospective data on new-onset hyperglycemia incidence were compared for all individuals seeking primary care services 6 weeks before and after the interve...
Patients without a known hyperglycemia history were provided the screening tool to determine risk status. Additional screening measures were implemented for patients identified as high risk on the ini...
A total of 52 (61.6%) of the 84 individuals who met inclusion criteria during the intervention period were diagnosed with new-onset chronic hyperglycemia. In contrast, 20 (22.5%) of the 89 individuals...
A diabetes risk assessment tool is quick and reliable in capturing high-risk individuals who would benefit from additional screening measures....
Neuropathic pain is associated with several clinical conditions, including anxiety, depression, sleep disorders, and decreased quality of life; however, less evaluated in prediabetes. This study aims ...
One hundred and seventy-two patients with prediabetes and 170 controls were included in this cross-sectional study. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale and Douleu...
Twenty-three (13.4%) and 12 (7%) patients with prediabetes were diagnosed with neuropathic pain using DN4 and LANSS questionnaires, respectively. Neuropathic pain rates of the patients were higher tha...
Neuropathic pain was increased in prediabetes by DN4 and LANNS questionnaires. An appropriate diagnosis of neuropathic pain in prediabetes may prevent patients from different pain-related clinical con...